Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
11,583,784
-
Share change
-
+710,407
-
Total reported value
-
$2,160,286,255
-
Put/Call ratio
-
208%
-
Price per share
-
$186.47
-
Number of holders
-
144
-
Value change
-
+$134,088,316
-
Number of buys
-
72
-
Number of sells
-
52
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2014
As of 31 Dec 2014,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
144 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,583,784 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, JPMORGAN CHASE & CO, MORGAN STANLEY, DEUTSCHE BANK AG\, UBS Group AG, CITIGROUP INC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, BARCLAYS PLC, and STATE OF WISCONSIN INVESTMENT BOARD.
This page lists
144
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.